LabCorp Acquires Covance Genomics Laboratory - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
LabCorp Acquires Covance Genomics Laboratory

Source: Applied Clinical Trials

LabCorp has acquired Covance Genomics Laboratory and its associated genomic analysis business. The laboratory is located in Seattle and provides complex genomic analysis, including gene expression array studies and next generation sequencing applications. As part of the acquisition, LabCorp and Covance have entered into a five-year services agreement to collaborate and continue offering specialty genomic services to Covance clients. The existing 50 employees, both scientists and staff, are now LabCorp employees.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here